✦ LIBER ✦

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database

✍ Scribed by Stephen F Sener; Amy Fremgen; Herman R Menck; David P Winchester

Book ID: 114355768
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 203 KB
Volume: 189
Category: Article
ISSN: 1072-7515
DOI: 10.1016/s1072-7515(99)00075-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pancreatic cancer: current status of tre

Pancreatic cancer: current status of treatment and survival of 16 071 patients diagnosed from 1981–1996, using the Japanese National Pancreatic Cancer Database

✍ S. Matsuno; S. Egawa; K. Shibuya; H. Shimamura; M. Sunamura; K. Takeda; H. Katoh 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 89 KB

The National Cancer Data Base report on

The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas : Improved survival of surgically resected patients, 1985–1996

✍ William G. Cance; Andrew K. Stewart; Herman R. Menck 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 3 views

The Commission on Cancer data from the National Cancer Data Base (NCDB) has previously reported data evaluating time trends in various cancers, including such elements as stage of disease at diagnosis, treatment, and survival for multiple tumor sites. In this report, data collected from 1985, 1986,

Survival and Prognostic Factors of Pancr

Survival and Prognostic Factors of Pancreatic Cancer Patients Diagnosed from 1995–1999 in the San Francisco Bay Area: A Populationbased Study with Active Follow-Up

✍ Z. Gong; E.A. Holly; P.M. Bracci 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Surgical treatment concepts for patients

Surgical treatment concepts for patients with pancreatic cancer in Germany—results from a national survey conducted among members of the “Chirurgische Arbeitsgemeinschaft Onkologie” (CAO) and the “Arbeitsgemeinschaft Internistische Onkologie” (AIO) of the Germany Cancer Society (DKG)

✍ Mirja Sargent; Stefan Boeck; Volker Heinemann; Karl-Walter Jauch; Thomas Seuffer 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 147 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB